Stoke Therapeutics, Inc.STOKNASDAQ
Loading
Price-to-sales ratio
3Y CAGR
-29.4%/yr
Annual compound
Percentile
P63
Within normal range
vs 3Y Ago
0.4x
Contraction
Streak
3 yr
Consecutive declineNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 10.19 | -37.5% |
| 2024 | 16.30 | -38.2% |
| 2023 | 26.36 | -8.9% |
| 2022 | 28.94 | - |
| 2021 | 0.00 | - |
| 2020 | 0.00 | - |
| 2019 | 0.00 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |